Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases

Journal of Immunology

Volumn 191, Issue 7, 2013, Pages 3594-3604

  Mayer, Marie C ^a   Breithaupt, Constanze ^b   Reindl, Markus ^c   Schanda, Kathrin ^c   Rostásy, Kevin ^c   Berger, Thomas ^c   Dale, Russell C ^d   Brilot, Fabienne ^d   Olsson, Tomas ^e   Jenne, Dieter ^f,g,h   Pröbstel, Anne Katrin ^a   Dornmair, Klaus ^a   Wekerle, Hartmut ^h   Hohlfeld, Reinhard ^a,i   Banwell, Brenda ^j   Bar Or, Amit ^k   Meinl, Edgar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g German Center for Lung Research   (Germany)

^h MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

ⁱ Munich Cluster for Systems Neurology ^*  (Germany)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k MCGILL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHRONIC RELAPSING INFLAMMATORY OPTIC NEURITIS; CONTROLLED STUDY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MULTIPLE SCLEROSIS; MUTATION; MYELITIS; MYELOOPTIC NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; OPTIC NEURITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; AUTOANTIBODIES; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; EPITOPES; FEMALE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; INFANT; INFLAMMATION; MALE; MICE; MIDDLE AGED; MODELS, MOLECULAR; MUTATION; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STABILITY; SEQUENCE ALIGNMENT; TRANSFECTION; YOUNG ADULT;

EID: 84885098431     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301296     Document Type: Article

References (58)

1. Vincent, A., C. G. Bien, S. R. Irani, and P. Waters. 2011. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol. 10:759-772.
2. Lancaster, E., and J. Dalmau. 2012. Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat. Rev. Neurol. 8:380-390.
3. Iorio, R., and V. A. Lennon. 2012. Neural antigen-specific autoimmune disorders. Immunol. Rev. 248:104-121.
4. Krumbholz, M., T. Derfuss, R. Hohlfeld, and E. Meinl. 2012. B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat. Rev. Neurol. 8:613-623.
5. Srivastava, R., M. Aslam, S. R. Kalluri, L. Schirmer, D. Buck, B. Tackenberg, V. Rothhammer, A. Chan, R. Gold, A. Berthele, et al. 2012. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N. Engl. J. Med. 367:115-123.
6. Quintana, F. J., M. F. Farez, V. Viglietta, A. H. Iglesias, Y. Merbl, G. Izquierdo, M. Lucas, A. S. Basso, S. J. Khoury, C. F. Lucchinetti, et al. 2008. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. USA 105:18889-18894.
7. Brunner, C., H. Lassmann, T. V. Waehneldt, J. M. Matthieu, and C. Linington. 1989. Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2', 3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52:296-304.
8. Mayer, M. C., and E. Meinl. 2012. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Ther. Adv. Neurol. Disord. 5:147-159.
9. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ oligodendrocyte glycoprotein. Am. J. Pathol. 130:443-454.
10. Schluesener, H. J., R. A. Sobel, C. Linington, and H. L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016-4021.
11. Genain, C. P., M. H. Nguyen, N. L. Letvin, R. Pearl, R. L. Davis, M. Adelman, M. B. Lees, C. Linington, and S. L. Hauser. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:2966-2974.
12. Brehm, U., S. J. Piddlesden, M. V. Gardinier, and C. Linington. 1999. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J. Neuroimmunol. 97:9-15.
13. von Büdingen, H. C., S. L. Hauser, J. C. Ouallet, N. Tanuma, T. Menge, and C. P. Genain. 2004. Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination. Eur. J. Immunol. 34:2072-2083.
14. Brilot, F., R. C. Dale, R. C. Selter, V. Grummel, S. R. Kalluri, M. Aslam, V. Busch, D. Zhou, S. Cepok, and B. Hemmer. 2009. Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease. Ann. Neurol. 66:833-842.
15. Di Pauli, F., S. Mader, K. Rostasy, K. Schanda, B. Bajer-Kornek, R. Ehling, F. Deisenhammer, M. Reindl, and T. Berger. 2011. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases. Clin. Immunol. 138:247-254.
16. Kitley, J., M. Woodhall, P. Waters, M. I. Leite, E. Devenney, J. Craig, J. Palace, and A. Vincent. 2012. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 79:1273-1277.
17. Lalive, P. H., M. G. Häusler, H. Maurey, Y. Mikaeloff, M. Tardieu, H. Wiendl, M. Schroeter, H. P. Hartung, B. C. Kieseier, and T. Menge. 2011. Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children. Mult. Scler. 17:297-302.
18. Mader, S., V. Gredler, K. Schanda, K. Rostasy, I. Dujmovic, K. Pfaller, A. Lutterotti, S. Jarius, F. Di Pauli, B. Kuenz, et al. 2011. Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J. Neuroinflammation 8:184.
19. McLaughlin, K. A., T. Chitnis, J. Newcombe, B. Franz, J. Kennedy, S. McArdel, J. Kuhle, L. Kappos, K. Rostasy, D. Pohl, et al. 2009. Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. J. Immunol. 183:4067-4076.
20. Pröbstel, A. K., K. Dornmair, R. Bittner, P. Sperl, D. Jenne, S. Magalhaes, A. Villalobos, C. Breithaupt, R. Weissert, U. Jacob, et al. 2011. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology 77:580-588.
21. Rostásy, K., S. Mader, E. Hennes, K. Schanda, V. Gredler, A. Guenther, A. Blaschek, C. Korenke, M. Pritsch, D. Pohl, et al. 2013. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult. Scler. 19:1052-1059.
22. Rostasy, K., S. Mader, K. Schanda, P. Huppke, J. Gärtner, V. Kraus, M. Karenfort, D. Tibussek, A. Blaschek, B. Bajer-Kornek, et al. 2012. Anti-myelin oligodendrocyte glycoprotein antibodies in pediatric patients with optic neuritis. Arch. Neurol. 69:752-756.
23. O'Connor, K. C., K. A. McLaughlin, P. L. De Jager, T. Chitnis, E. Bettelli, C. Xu, W. H. Robinson, S. V. Cherry, A. Bar-Or, B. Banwell, et al. 2007. Selfantigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat. Med. 13:211-217.
24. Breithaupt, C., B. Schäfer, H. Pellkofer, R. Huber, C. Linington, and U. Jacob. 2008. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. J. Immunol. 181:1255-1263.
25. Gardinier, M. V., and J. M. Matthieu. 1993. Cloning and cDNA sequence analysis of myelin/oligodendrocyte glycoprotein: a novel member of the immunoglobulin gene superfamily. Schweiz. Arch. Neurol. Psychiatr. 144:201-207.
26. Clements, C. S., H. H. Reid, T. Beddoe, F. E. Tynan, M. A. Perugini, T. G. Johns, C. C. Bernard, and J. Rossjohn. 2003. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc. Natl. Acad. Sci. USA 100:11059-11064.
27. Breithaupt, C., A. Schubart, H. Zander, A. Skerra, R. Huber, C. Linington, and U. Jacob. 2003. Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein. Proc. Natl. Acad. Sci. USA 100:9446-9451.
28. Schwede, T., J. Kopp, N. Guex, and M. C. Peitsch. 2003. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 31:3381-3385.
29. Barton, G. J. 1993. ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng. 6:37-40.
30. Linnington, C., M. Webb, and P. L. Woodhams. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6:387-396.
31. Piddlesden, S. J., H. Lassmann, F. Zimprich, B. P. Morgan, and C. Linington. 1993. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143:555-564.
32. Ramaraj, T., T. Angel, E. A. Dratz, A. J. Jesaitis, and B. Mumey. 2012. Antigenantibody interface properties: composition, residue interactions, and features of 53 non-redundant structures. Biochim. Biophys. Acta 1824:520-532.
33. Thornton, J. M., M. S. Edwards, W. R. Taylor, and D. J. Barlow. 1986. Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J. 5:409-413.
34. Lennon, V. A., D. M. Wingerchuk, T. J. Kryzer, S. J. Pittock, C. F. Lucchinetti, K. Fujihara, I. Nakashima, and B. G. Weinshenker. 2004. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106-2112.
35. Bennett, J. L., C. Lam, S. R. Kalluri, P. Saikali, K. Bautista, C. Dupree, M. Glogowska, D. Case, J. P. Antel, G. P. Owens, et al. 2009. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann. Neurol. 66:617-629.
36. Bradl, M., T. Misu, T. Takahashi, M. Watanabe, S. Mader, M. Reindl, M. Adzemovic, J. Bauer, T. Berger, K. Fujihara, et al. 2009. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann. Neurol. 66:630-643.
37. Saadoun, S., P. Waters, B. A. Bell, A. Vincent, A. S. Verkman, and M. C. Papadopoulos. 2010. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 133:349-361.
38. Kinoshita, M., Y. Nakatsuji, T. Kimura, M. Moriya, K. Takata, T. Okuno, A. Kumanogoh, K. Kajiyama, H. Yoshikawa, and S. Sakoda. 2009. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. Biochem. Biophys. Res. Commun. 386:623-627.
39. Zhou, D., R. Srivastava, S. Nessler, V. Grummel, N. Sommer, W. Brück, H. P. Hartung, C. Stadelmann, and B. Hemmer. 2006. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103:19057-19062.
40. von Büdingen, H. C., S. L. Hauser, A. Fuhrmann, C. B. Nabavi, J. I. Lee, and C. P. Genain. 2002. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. USA 99:8207-8212.
41. Marta, C. B., A. R. Oliver, R. A. Sweet, S. E. Pfeiffer, and N. H. Ruddle. 2005. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc. Natl. Acad. Sci. USA 102:13992-13997.
42. Henry, R. A., P. L. Kendall, and J. W. Thomas. 2012. Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes. Diabetes 61:2037-2044.
43. Tradtrantip, L., H. Zhang, S. Saadoun, P. W. Phuan, C. Lam, M. C. Papadopoulos, J. L. Bennett, and A. S. Verkman. 2012. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann. Neurol. 71:314-322.
44. Kroepfl, J. F., L. R. Viise, A. J. Charron, C. Linington, and M. V. Gardinier. 1996. Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J. Neurochem. 67:2219-2222.
45. Tzartos, S. J., M. E. Seybold, and J. M. Lindstrom. 1982. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 79:188-192.
46. Luo, J., P. Taylor, M. Losen, M. H. de Baets, G. D. Shelton, and J. Lindstrom. 2009. Main immunogenic region structure promotes binding of conformationdependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and agonist sensitivity. J. Neurosci. 29:13898-13908.
47. Xu, Y., Y. Zhang, C. Y. Liu, B. Peng, J. M. Wang, X. J. Zhang, H. F. Li, and L. Y. Cui. 2012. Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity. Chin. Med. J. (Engl.) 125:3207-3210.
48. Haase, C. G., J. Guggenmos, U. Brehm, M. Andersson, T. Olsson, M. Reindl, J. M. Schneidewind, U. K. Zettl, F. Heidenreich, T. Berger, et al. 2001. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114:220-225.
49. Khalil, M., M. Reindl, A. Lutterotti, B. Kuenz, R. Ehling, C. Gneiss, P. Lackner, F. Deisenhammer, and T. Berger. 2006. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments. J. Neuroimmunol. 174:147-156.
50. Zielinska, D. F., F. Gnad, J. R. Wisniewski, and M. Mann. 2010. Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141:897-907.
51. Koch, M., M. Pancera, P. D. Kwong, P. Kolchinsky, C. Grundner, L. Wang, W. A. Hendrickson, J. Sodroski, and R. Wyatt. 2003. Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition. Virology 313:387-400.
52. Xiao, Q., K. Yu, Y. Y Cui, and H. C. Hartzell. 2009. Dysregulation of human bestrophin-1 by ceramide-induced dephosphorylation. J. Physiol. 587:4379-4391.
53. Blom, N., S. Gammeltoft, and S. Brunak. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294:1351-1362.
54. Vincent, A., L. Jacobson, and P. Shillito. 1994. Response to human acetylcholine receptor alpha 138-199:determinant spreading initiates autoimmunity to selfantigen in rabbits. Immunol. Lett. 39:269-275.
55. Mori, T., H. Ohira, M. Kuroda, M. Kato, Y. Yamaguchi, and H. Kochi. 2012. Characterization of Autoantibodies against the E1a Subunit of Branched-Chain 2-Oxoacid Dehydrogenase in Patients with Primary Biliary Cirrhosis. Int. J. Hepatol. 2012:369740.
56. Sokolove, J., R. Bromberg, K. D. Deane, L. J. Lahey, L. A. Derber, P. E. Chandra, J. D. Edison, W. R. Gilliland, R. J. Tibshirani, J. M. Norris, et al. 2012. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE 7:e35296.
57. Amanna, I. J., N. E. Carlson, and M. K. Slifka. 2007. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357:1903-1915.
58. Manz, R. A., A. E. Hauser, F. Hiepe, and A. Radbruch. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23:367-386.